Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ian Parish

17PUBLICATIONS
116CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyHaematological tumoursNanochemistryInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

Sort by Publication Date:
|Feb 17, 2026
High efficiency CRISPR knock-in demonstrates that TCF1 is insufficient to reverse T cell exhaustion.

Maria N de Menezes, Amanda X Y Chen, Nihali Kulkarni

|Feb 10, 2026
Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8<sup>+</sup> T cells in lymph nodes.

Junyun Lai, Cheok Weng Chan, Jesse D Armitage

|Jan 16, 2026
Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy.

Alberto G Conti, Alexander C Evans, Teresa von Linde

|Jul 03, 2025
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors.

Kevin Sek, Amanda X Y Chen, Thomas Cole

|Jul 03, 2025
Rewiring endogenous genes in CAR T cells for tumour-restricted payload delivery.

Amanda X Y Chen, Kah Min Yap, Joelle S Kim

|May 06, 2025
Spatial and stoichiometric in situ analysis of biomolecular oligomerization at single-protein resolution.

Luciano A Masullo, Rafal Kowalewski, Monique Honsa

Pageof 3

Frequent Collaborators

8 joint publications

Paul Beavis

6 joint publications

Isabelle Munoz

6 joint publications

Kevin Sek

6 joint publications

Phillip K Darcy

5 joint publications

Kirsten L Todd

5 joint publications

Christina Scheffler

5 joint publications

Emily B Derrick

5 joint publications

Jane Oliaro

5 joint publications

Kah Min Yap

4 joint publications

Junyun Lai

Frequent Collaborators

8 joint publications

Paul Beavis

6 joint publications

Isabelle Munoz

6 joint publications

Kevin Sek

6 joint publications

Phillip K Darcy

Top Related Videos

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation
09:29

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Published on : Feb 28, 2025

3.5K
Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8<sup>+</sup> T Cells During Tumorigenesis
07:45

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8<sup>+</sup> T Cells During Tumorigenesis

Published on : Jan 26, 2024

2.8K
<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on : Jan 14, 2011

15.2K
See more related videos

Top Related Videos

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation
09:29

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Published on : Feb 28, 2025

3.5K
Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8<sup>+</sup> T Cells During Tumorigenesis
07:45

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8<sup>+</sup> T Cells During Tumorigenesis

Published on : Jan 26, 2024

2.8K
<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on : Jan 14, 2011

15.2K
See more related videos